ARGENX SE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 387 USD | -0.35% |
|
+0.05% | +1.73% |
| Jun. 13 | Pliant Therapeutics, Inc. Appoints Steve Krognes to Its Board of Directors | CI |
| Jun. 13 | European Equities Traded in the US as American Depositary Receipts Sharply Lower in Thursday Trading | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 124B | ||||||
| 111B | ||||||
| 23.17B | - | |||||
| 17.42B | ||||||
| 17.42B | - |
- Stock Market
- Equities
- ARGX Stock
- ARGX Stock
- Charts argenx SE
- Sector Chart
